Search results
FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
USA Today· 1 hour agoThe recommendation came despite pointed questions from advisory committee members about the...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 2 hours agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
Alzheimer’s drug from Eli Lilly wins backing of FDA committee
Washington Post· 43 minutes agoThe medication doesn’t cure or halt Alzheimer’s disease but was shown in a clinical trial to slow...
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 3 days agoThe rest of the group took a placebo with ritonavir, which doesn't work against the SARS-CoV-2 virus on its own. Ritonavir enhanced the placebo because...
The Power of Placebo To Boost High Performance and Self-Belief
Sean Kernan via Yahoo News· 6 days ago“Want another beer Brian?” My buddy Adam said. “Sure! I’ve already had three, but why not,” Brian...
New Alzheimer’s treatment drug gets support from FDA advisory panel
WXYZ-TV Detroit· 31 minutes agoIf approved by the FDA, it would become the second Alzheimer’s drug on the market. Alzheimer’s is an incurable disease that affects nearly 7 million Americans today. An outside panel of advisors ...
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
New York Times· 36 minutes agoThe modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously. Gina Kolata and Pam Belluck have reported for years on progress and disappointments ...
Michael Mosley, exuberant medical broadcaster who popularised the 5:2 diet – obituary
The Telegraph via Yahoo News· 1 day agoDr Michael Mosley, who has died in Greece aged 67, was a Tiggerish presenter of television science...
A call to ban phones in school
Politico· 6 days agoWhy it matters: There...National Institute on Drug Abuse, Nora Volkow, compared the hype for psychedelics as a cure for mental illness to belief in...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 7 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
